- Free from Publisher RA Deyo - Quality and Safety in Health Care, 2002 - qshc.bmj.com On a fine March day in 1995 Dr Bruce Psaty ascended the podium to present a
scientific paper as he had many times before. At a hotel in San Antonio he was
speaking before the Epidemiology and Prevention Council of the American ... Related articles - BL Direct - All 7 versions
M Pahor, BM Psaty, MH Alderman, WB … - The Lancet, 2001 - Elsevier Our main objective was to find out whether calcium antagonists used as
first-line therapy are better than, equal to, or worse than other treatments in
lowering the incidence of cardiovascular complications of hypertension. The ... Cited by 7 - Related articles - BL Direct - All 2 versions
DB Stryer, P Lurie, LA Bero - JAMA, 1996 - Am Med Assoc —In response to the article by Dr Psaty and colleagues, 1 thousands of
physicians across the country received a "Dear Doctor" letter from an
internationally recognized expert in the treatment of hypertension. The ... Cited by 3 - Related articles - All 3 versions
- ►annals.org [PDF] CD Furberg, BM Psaty, M Pahor, MH … - Annals of Internal Medicine, 2001 - Am Coll Physicians Several recent comparative trials in hypertension have reported that similar
blood pressure reductions may not necessarily trans- late into similar
reductions in risk for cardiovascular complications. Thus, the method used ... Cited by 47 - Related articles - BL Direct - All 3 versions
- ►simg.it [PDF] MH Alderman - JAMA, 2002 - Am Med Assoc To address these issues, 1094 participants were randomized at 21 US sites to
either conventional or lower mean arterial pressure goals (102 to 107 mm Hg or
92 mm Hg or less, respectively). In-treatment blood pressures were 127/77 ... Cited by 3 - Related articles - BL Direct - All 7 versions
R DISEKER, D ROBLIN - 69.0.204.76 ROBERT J. ANDERSON, PharmD, is a Professor, Department of Clinical and
Administrative Sciences, Mercer University, Southern School of Pharmacy, and a
Clinical Pharmacy Specialist, Kaiser Permanente, Georgia Region, Atlanta; ... Related articles - View as HTML - All 4 versions
S Tobe, M Epstein - Current Hypertension Reports, 2002 - Springer Introduction The treatment of hypertension is proven to reduce the risk for
cardiovascular, cerebrovascular, and renal disease. To lower blood pressure to
target, the use of combinations of antihypertensives is a necessity in most ... Cited by 9 - Related articles - BL Direct - All 2 versions
E Ambrosioni - pdfs.journals.adisonline.com Abstract The ALLHAT trial (Antihypertensive and Lipid Lowering treatment to
prevent Heart Attack Trial) is the largest study ever to focus on the treatment
of patients with hypertension and the authors' conclusions have been widely ... Related articles
E Ambrosioni - High Blood Pressure &# 38; Cardiovascular Prevention, 2003 - ingentaconnect.com Abstract The ALLHAT trial (Antihypertensive and Lipid Lowering treatment to
prevent Heart Attack Trial) is the largest study ever to focus on the treatment
of patients with hypertension and the authors' conclusions have been widely ... Related articles - BL Direct - All 2 versions
MA Weber - The Journal of clinical hypertension(Greenwich, Conn.), 2003 - cat.inist.fr The ALLHAT report: A case of information and misinformation. Michael A
WEBER The Journal of clinical hypertension(Greenwich, Conn ... Cited by 50 - Related articles - BL Direct - All 3 versions
